213 related articles for article (PubMed ID: 32914748)
1. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017.
Appelt S; Jacob D; Rohleder AM; Bråve A; Szekely Björndal Å; Di Caro A; Grunow R;
Euro Surveill; 2020 Sep; 25(36):. PubMed ID: 32914748
[TBL] [Abstract][Full Text] [Related]
2. Biosafety and biosecurity measures: management of biosafety level 3 facilities.
Zaki AN
Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S70-4. PubMed ID: 20801002
[TBL] [Abstract][Full Text] [Related]
3. Challenges in Implementing a Biorisk Management Program at Universitas Indonesia: A Checklist Tool for Biorisk Management.
Naroeni A; Bachtiar EW; Ibrahim F; Bela B; Kusminanti Y; Pujiriani I; Lestari F
Health Secur; 2016; 14(6):375-381. PubMed ID: 27830940
[TBL] [Abstract][Full Text] [Related]
4. The European network of Biosafety-Level-4 laboratories: enhancing European preparedness for new health threats.
Nisii C; Castilletti C; Di Caro A; Capobianchi MR; Brown D; Lloyd G; Gunther S; Lundkvist A; Pletschette M; Ippolito G;
Clin Microbiol Infect; 2009 Aug; 15(8):720-6. PubMed ID: 19754729
[TBL] [Abstract][Full Text] [Related]
5. Harmonization of European laboratory response networks by implementing CWA 15793: use of a gap analysis and an "insider" exercise as tools.
Sundqvist B; Bengtsson UA; Wisselink HJ; Peeters BP; van Rotterdam B; Kampert E; Bereczky S; Johan Olsson NG; Szekely Björndal A; Zini S; Allix S; Knutsson R
Biosecur Bioterror; 2013 Sep; 11 Suppl 1():S36-44. PubMed ID: 23971820
[TBL] [Abstract][Full Text] [Related]
6. Status, quality and specific needs of Ebola virus diagnostic capacity and capability in laboratories of the two European preparedness laboratory networks EMERGE and EVD-LabNet.
Reusken CB; Mögling R; Smit PW; Grunow R; Ippolito G; Di Caro A; Koopmans M
Euro Surveill; 2018 May; 23(19):. PubMed ID: 29766839
[TBL] [Abstract][Full Text] [Related]
7. European perspective of 2-person rule for biosafety level 4 laboratories.
Ippolito G; Nisii C; Di Caro A; Brown D; Gopal R; Hewson R; Lloyd G; Gunther S; Eickmann M; Mirazimi A; Koivula T; Georges Courbot MC; Raoul H; Capobianchi MR
Emerg Infect Dis; 2009 Nov; 15(11):1858. PubMed ID: 19891889
[No Abstract] [Full Text] [Related]
8. Biosafety news: introducing EBSA--the European Biosafety Association.
Biotechnol J; 2007 Mar; 2(3):285. PubMed ID: 17354214
[No Abstract] [Full Text] [Related]
9. [Biorisk Management for Clinical Diagnostic Laboratories].
Shigematsu M
Rinsho Byori; 2016 Nov; 64(11):1279-1289. PubMed ID: 30695310
[TBL] [Abstract][Full Text] [Related]
10. The Main Biological Hazards in Animal Biosafety Level 2 Facilities and Strategies for Control.
Li XY; Xue KN; Jiang JS; Lu XC
Biomed Environ Sci; 2016 Apr; 29(4):300-4. PubMed ID: 27241742
[TBL] [Abstract][Full Text] [Related]
11. The contribution of the European high containment laboratories during the 2014-2015 Ebola Virus Disease emergency.
Nisii C; Vincenti D; Fusco FM; Schmidt-Chanasit J; Carbonnelle C; Raoul H; Eickmann M; Hewson R; Brave A; Nuncio S; Sanchez-Seco MP; Palyi B; Kis Z; Zange S; Nitsche A; Kurth A; Strasser M; Capobianchi MR; Ozin A; Guglielmetti P; Menel-Lemos C; Jacob D; Grunow R; Ippolito G; Di Caro A
Clin Microbiol Infect; 2017 Feb; 23(2):58-60. PubMed ID: 27404371
[No Abstract] [Full Text] [Related]
12. Biosafety: guidelines for working with pathogenic and infectious microorganisms.
Coico R; Lunn G
Curr Protoc Immunol; 2005 Nov; Appendix 1():A.1V.1-A.1V.8. PubMed ID: 18432937
[TBL] [Abstract][Full Text] [Related]
13. Containing risk.
Nature; 2009 Nov; 462(7270):137. PubMed ID: 19907446
[TBL] [Abstract][Full Text] [Related]
14. Issues in biosecurity and biosafety.
Nordmann BD
Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S66-9. PubMed ID: 20696555
[TBL] [Abstract][Full Text] [Related]
15. International Society for Analytical Cytology biosafety standard for sorting of unfixed cells.
Schmid I; Lambert C; Ambrozak D; Marti GE; Moss DM; Perfetto SP;
Cytometry A; 2007 Jun; 71(6):414-37. PubMed ID: 17385740
[TBL] [Abstract][Full Text] [Related]
16. Smart Card Decontamination in a High-Containment Laboratory.
Gabbert LR; Smith JD; Neilan JG; Ferman GS; Rasmussen MV
Health Secur; 2018; 16(4):244-251. PubMed ID: 30096256
[TBL] [Abstract][Full Text] [Related]
17. Biosafety Level-4 laboratories in Europe: opportunities for public health, diagnostics, and research.
Nisii C; Castilletti C; Raoul H; Hewson R; Brown D; Gopal R; Eickmann M; Gunther S; Mirazimi A; Koivula T; Feldmann H; Di Caro A; Capobianchi MR; Ippolito G
PLoS Pathog; 2013 Jan; 9(1):e1003105. PubMed ID: 23349630
[No Abstract] [Full Text] [Related]
18. Certification & validation of biosafety level-2 & biosafety level-3 laboratories in Indian settings & common issues.
Mourya DT; Yadav PD; Khare A; Khan AH
Indian J Med Res; 2017 Oct; 146(4):459-467. PubMed ID: 29434059
[TBL] [Abstract][Full Text] [Related]
19. Arthropod containment guidelines. A project of the American Committee of Medical Entomology and American Society of Tropical Medicine and Hygiene.
;
Vector Borne Zoonotic Dis; 2003; 3(2):61-98. PubMed ID: 12908960
[No Abstract] [Full Text] [Related]
20. National Laboratory Planning: Developing Sustainable Biocontainment Laboratories in Limited Resource Areas.
Yeh KB; Adams M; Stamper PD; Dasgupta D; Hewson R; Buck CD; Richards AL; Hay J
Health Secur; 2016; 14(5):323-30. PubMed ID: 27559843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
